CTRI/2020/02/023359CompletedPhase 3
A randomized, double-blind, placebo-controlled clinical study to evaluate comparative clinical Efficacy and Safety of BHC9633CP Tinospora cordifolia in Immune Support Adult Subjects
Botanic Healthcare Pvt Ltd0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Completed
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1.Subjects aged 40-70 years of age and of either sex
- •2. Subjects who were disposed to give consent to the study and willing for follow-
- •3.Subjects who are willing to sign ICF
Exclusion Criteria
- •1.Children with genetic disorders, severe or chronic illnesses, congenital diseases, mentally challenged and those on other immunostimulant drugs were excluded
Investigators
Similar Trials
Active, not recruiting
Phase 1
A clinical trial where patients with the lung disease autoimmunePulmonary Alveolar Proteinosis will be given the drug molgramostim nebulizer solution byinhalation.Autoimmune Pulmonary Alveolar Proteinosis (aPAP)MedDRA version: 21.1Level: LLTClassification code 10037316Term: Pulmonary alveolar proteinosisSystem Organ Class: 100000004855EUCTR2020-001263-85-ROSavara ApS160
Completed
Not Applicable
Clinical trial of fluoride varnish in preventing dental caries of Sjögren’s syndrome patientsISRCTN85164658Research Grants Council of Hong Kong120
Recruiting
Phase 3
Once-daily inhaled molgramostim nebulizer solution in aPAP.Autoimmune Pulmonary Alveolar Proteinosis(aPAP)JPRN-jRCT2051210036Desai Dhaval40
Active, not recruiting
Phase 1
A clinical trial where patients with the lung disease autoimmunePulmonary Alveolar Proteinosis will be given the drug molgramostim nebulizer solution by inhalation.Autoimmune Pulmonary Alveolar Proteinosis (aPAP)MedDRA version: 21.1Level: LLTClassification code 10037316Term: Pulmonary alveolar proteinosisSystem Organ Class: 100000004855EUCTR2020-001263-85-DESavara ApS160
Completed
Not Applicable
A Clinical study to evaluate the efficacy and tolerability of 5-LOXIN in patients with mild osteoarthritis of kneeCTRI/2020/10/028725Ju Yeong NS Co Ltd100